Giles Lisa M.
Insider CIK 1568850 · MIST Director · GNMK Director · DRTX Director · HCWB Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| MIST Milestone Pharmaceuticals | A Award deriv | 2026-06-10 | 2026-06-12 | 77,000 | — | $0 | 77,000 | SEC↗ |
| MIST Milestone Pharmaceuticals | A Award deriv | 2025-06-10 | 2025-06-12 | 40,000 | — | $0 | 40,000 | SEC↗ |
| MIST Milestone Pharmaceuticals | A Award deriv | 2024-08-28 | 2024-08-29 | 40,000 | — | $0 | 40,000 | SEC↗ |
| HCWB HCW Biologics Inc. | A Award deriv | 2024-06-14 | 2024-06-17 | 12,500 | — | $0 | 12,500 | SEC↗ |
| HCWB HCW Biologics Inc. | A Award | 2024-02-20 | 2024-02-22 | 35,715 | $1.40 | $50.0K | 35,815 | SEC↗ |
| HCWB HCW Biologics Inc. | A Award deriv | 2023-06-13 | 2023-06-15 | 12,500 | — | $0 | 12,500 | SEC↗ |
| MIST Milestone Pharmaceuticals | A Award deriv | 2023-06-07 | 2023-06-09 | 30,000 | — | $0 | 30,000 | SEC↗ |
| MIST Milestone Pharmaceuticals | A Award deriv | 2022-07-05 | 2022-08-11 | 30,000 | — | $0 | 30,000 | SEC↗ |
| HCWB HCW Biologics Inc. | A Award deriv | 2022-06-15 | 2022-06-17 | 41,841 | — | $0 | 41,841 | SEC↗ |
| HCWB HCW Biologics Inc. | A Award deriv | 2021-10-26 | 2021-10-28 | 37,037 | — | $0 | 37,037 | SEC↗ |
| MIST Milestone Pharmaceuticals | A Award deriv | 2021-06-14 | 2021-07-29 | 30,000 | — | $0 | 30,000 | SEC↗ |
| GNMK GenMark Diagnostics, Inc. | D To issuer deriv | 2021-04-22 | 2021-04-22 | 19,062 | — | $0 | 0 | SEC↗ |
| GNMK GenMark Diagnostics, Inc. | U Tender | 2021-04-22 | 2021-04-22 | 5,500 | $24.05 | $132.3K | 0 | SEC↗ |
| GNMK GenMark Diagnostics, Inc. | U Tender | 2021-04-22 | 2021-04-22 | 81,572 | $24.05 | $1.96M | 0 | SEC↗ |
| GNMK GenMark Diagnostics, Inc. | A Award | 2021-02-18 | 2021-02-19 | 7,782 | — | $0 | 81,572 | SEC↗ |
| MIST Milestone Pharmaceuticals | A Award deriv | 2020-10-01 | 2020-10-05 | 30,000 | — | $0 | 30,000 | SEC↗ |
| GNMK GenMark Diagnostics, Inc. | A Award | 2020-05-29 | 2020-06-02 | 13,825 | — | $0 | 73,790 | SEC↗ |
| GNMK GenMark Diagnostics, Inc. | A Award | 2019-10-30 | 2019-11-01 | 528 | — | $0 | 59,965 | SEC↗ |
| GNMK GenMark Diagnostics, Inc. | A Award | 2019-07-31 | 2019-08-02 | 702 | — | $0 | 59,437 | SEC↗ |
| GNMK GenMark Diagnostics, Inc. | A Award | 2019-05-31 | 2019-06-04 | 17,937 | — | $0 | 58,735 | SEC↗ |
| GNMK GenMark Diagnostics, Inc. | A Award | 2018-05-24 | 2018-05-29 | 17,107 | — | $0 | 40,798 | SEC↗ |
| GNMK GenMark Diagnostics, Inc. | A Award | 2017-05-25 | 2017-05-30 | 6,981 | — | $0 | 23,691 | SEC↗ |
| GNMK GenMark Diagnostics, Inc. | P Buy | 2016-08-12 | 2016-08-16 | 823 | $9.40 | $7.7K | 5,323 | SEC↗ |
| GNMK GenMark Diagnostics, Inc. | P Buy | 2016-08-12 | 2016-08-22 | 177 | $9.40 | $1.7K | 5,500 | SEC↗ |
| GNMK GenMark Diagnostics, Inc. | A Award | 2016-05-26 | 2016-05-31 | 8,497 | — | $0 | 16,710 | SEC↗ |
| GNMK GenMark Diagnostics, Inc. | P Buy | 2015-11-03 | 2015-11-04 | 4,000 | $6.60 | $26.4K | 4,500 | SEC↗ |
| GNMK GenMark Diagnostics, Inc. | A Award | 2015-05-28 | 2015-06-01 | 6,483 | — | $0 | 8,213 | SEC↗ |
| GNMK GenMark Diagnostics, Inc. | A Award deriv | 2015-02-19 | 2015-02-23 | 19,062 | — | $0 | 19,062 | SEC↗ |
| GNMK GenMark Diagnostics, Inc. | A Award | 2015-02-19 | 2015-02-23 | 1,730 | — | $0 | 1,730 | SEC↗ |
| DRTX Durata Therapeutics, Inc. | D To issuer deriv | 2014-11-17 | 2014-11-19 | 1,875 | — | $0 | 0 | SEC↗ |
| DRTX Durata Therapeutics, Inc. | D To issuer deriv | 2014-11-17 | 2014-11-19 | 11,145 | — | $0 | 0 | SEC↗ |
| DRTX Durata Therapeutics, Inc. | D To issuer deriv | 2014-11-17 | 2014-11-19 | 8,575 | — | $0 | 0 | SEC↗ |
| DRTX Durata Therapeutics, Inc. | D To issuer deriv | 2014-11-17 | 2014-11-19 | 6,250 | — | $0 | 0 | SEC↗ |
| DRTX Durata Therapeutics, Inc. | D To issuer | 2014-11-17 | 2014-11-19 | 2,500 | — | $0 | 0 | SEC↗ |
| DRTX Durata Therapeutics, Inc. | A Award deriv | 2014-05-21 | 2014-05-22 | 8,575 | — | $0 | 27,845 | SEC↗ |
| DRTX Durata Therapeutics, Inc. | P Buy | 2013-12-03 | 2013-12-03 | 1,000 | $10.95 | $10.9K | 1,000 | SEC↗ |
| DRTX Durata Therapeutics, Inc. | A Award deriv | 2013-05-16 | 2013-05-20 | 1,875 | — | $0 | 8,125 | SEC↗ |
| DRTX Durata Therapeutics, Inc. | A Award deriv | 2013-05-16 | 2013-05-20 | 11,145 | — | $0 | 19,270 | SEC↗ |
| DRTX Durata Therapeutics, Inc. | P Buy | 2012-08-06 | 2014-01-23 | 500 | $8.25 | $4.1K | 1,500 | SEC↗ |